Not all intravenous immunoglobulins are the same: Appropriate selection in patients with compromised renal function

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 296-297

  McRogers, Rene ^a  

^a Scientific Communications Scientific Relations   (United States)

Author keywords

Acute renal failure; Gamimune N; Gamunex; Glycine; IGIV; Intravenous immunoglobulin; IVIg; Sucrose

Indexed keywords

GAMINUNE; GAMINUNE N; GAMMAR P; GLUCOSE; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; MALTOSE; SUCROSE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; DRUG FORMULATION; DRUG INDICATION; DRUG LABELING; DRUG MANUFACTURE; FOOD AND DRUG ADMINISTRATION; HUMAN; KIDNEY FUNCTION; LICENSING; PATIENT SELECTION; RARE DISEASE; SHORT SURVEY;

DRUG INDUSTRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FAILURE, ACUTE;

EID: 32044469189     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.296     Document Type: Short Survey

References (8)

1. Itkin YM, Trujillo TC. Intravenous immunoglobulin-associated acute renal failure: case series and literature review. Pharmacotherapy 2005;25(6):886-92.
2. Lemm G. Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy. Neurology 2002;59(12 suppl 6):S28-S32.
3. Centers for Disease Control and Prevention. Renal insufficiency and failure associated with immune globulin intravenous therapy - United States, 1985-1998. MMWR Morb Mortal Wkly Rep 1999;48(24):518-21.
4. Mahadevia PJ, Strell J, Kunaprayoon D, et al. Cost savings from intravenous immunoglobulin manufactured from chromatography/caprylate (IGIV-C) in persons with primary humoral immunodeficiency disorder. Value Health 2005;8(4):488-94.
5. Gelfand EW, Winkelstein J. Are all IGIVs the same [letter]? J Allergy Clin Immunol 2002;110(6):938.
6. McCue JP, Hein RH, Tenold R. Three generations of immunoglobulin G preparations for clinical use. Rev Infect Dis 1986;8(suppl 4):374-81.
7. Food and Drug Administration. FDA warning letter, September 24, 1999. Available from http://www.fda.gov/cber/ltr/igivrenal.htm. Accessed September 24, 1999.
8. Lebing W, Remington KM, Schreiner C. Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography. Vox Sang 2003;84(3):193-201.